Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1418 studies found for:    menstruation OR menstrual cycle AND NICHD
Show Display Options
Rank Status Study
21 Terminated
Has Results
Study to Evaluate Menses Induction in Women Administered Proellex
Condition: Amenorrhea
Interventions: Drug: Placebo;   Drug: Proellex
22 Enrolling by invitation An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
23 Recruiting LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Heavy Menstrual Bleeding;   Uterine Fibroid
Interventions: Drug: Relugolix;   Drug: Low-dose Hormonal Add-back;   Drug: Relugolix Placebo;   Drug: Low-dose Hormonal Add-back Placebo
24 Recruiting LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Heavy Menstrual Bleeding;   Uterine Fibroid
Interventions: Drug: Relugolix;   Drug: Low-dose Hormonal Add-back;   Drug: Relugolix Placebo;   Drug: Low-dose Hormonal Add-back Placebo
25 Not yet recruiting Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
Conditions: Improve Quality of Life;   Heavy Menstrual Bleeding
Interventions: Drug: combined contraceptive pills (microcept);   Drug: medroxyprogesterone acetate (progest);   Drug: mefenamic acid (ponstan forte)
26 Not yet recruiting Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo + Placebo Add-back;   Drug: OBE2109 + Placebo Add-back;   Drug: OBE2109 + Add-back
27 Recruiting Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo + Placebo Add-back;   Drug: OBE2109 + Placebo Add-back;   Drug: OBE2109 + Add-back
28 Completed Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh
Condition: Menstrual Regulation
Intervention: Drug: Mifepristone and misoprostol
29 Withdrawn Continuous Use of the Contraceptive Patch and the Personal Economic Impact.
Conditions: Dysmenorrhea;   Menstruation Disturbances;   Menstruation Disorders
Intervention: Drug: ORTHO EVRA, the contraceptive patch
30 Completed Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
Condition: Healthy
Interventions: Drug: Fluoxetine;   Drug: Zolpidem;   Drug: Progesterone
31 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Elagolix + Estradiol/Norethindrone Acetate
32 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
33 Completed Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Condition: Menstrual Migraine (MM) Headaches
Interventions: Drug: Frovatriptan;   Drug: Usual Care
34 Completed Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity
Condition: Menstrual Irregularity
Intervention: Behavioral: EAMD+Calories
35 Completed Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
Conditions: Migraine;   Migraine Disorders
Intervention: Drug: sumatriptan succinate/naproxen sodium
36 Not yet recruiting Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom
Condition: Heavy Menstrual Bleeding
Intervention: Device: Librata Endometrial Ablation
37 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
38 Completed A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine
Condition: HIV
Interventions: Drug: Dapivirine Vaginal Ring-004 and no tampons;   Drug: Dapivirine Vaginal Ring-004 with tampons;   Drug: Dapivirine Vaginal Ring-004 with no menses;   Drug: Dapivirine Vaginal Ring-004 and same ring inserted after menses;   Drug: Dapivirine Vaginal Ring-004 and new ring inserted after menses
39 Unknown  Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
Conditions: Heavy Menstrual Bleeding;   Menorrhagia;   Hypermenorrhea
Interventions: Drug: Norethindrone acetate pretreatment;   Other: No pretreatment
40 Completed Prevalence of Menstrual Cycle Related Pain Complains in Adolescents and Young Adults
Conditions: Dysmenorrhea;   Pelvic Pain
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.